Coffee and Longevity: How to Read the Cohort Data

The Annals of Internal Medicine published a sweeping 2022 analysis of 171,616 UK adults followed for a median of seven years. Those who drank 1.5 to 3.5 cups per day were up to 30 percent less likely to die during the study period — including, surprisingly, those who added a modest amount of sugar. The relationship held even after adjusting for smoking, exercise, BMI, and overall diet.

Earlier work by the U.S. National Institutes of Health, tracking more than 400,000 adults over 13 years, found similar reductions in mortality from heart disease, stroke, diabetes, and respiratory illness among regular coffee drinkers.

Some cohort analyses also report associations with cause-specific mortality. These narrower estimates can be less stable because they involve fewer events and more comparisons, so they should not be read as prevention claims.

Associations have also appeared in some decaffeinated-coffee groups, one reason researchers continue to study explanations beyond caffeine. The finding still does not establish cause and effect.

Researchers have proposed several biological pathways, but a plausible mechanism does not turn an observational association into a proven effect. Preparation, additives, smoking, sleep, income, and baseline health can all influence results.

The practical conclusion is not a longevity prescription. People who enjoy coffee can read the findings as reassuring population research while making personal intake decisions around sleep, sensitivity, medications, pregnancy, and clinical advice.